Erelzi and Liver function test abnormal - a phase IV clinical study of FDA data
Summary:
Liver function test abnormal is reported as a side effect among people who take Erelzi (etanercept-szzs), especially for people who are female, 2-9 old, have been taking the drug for 1 - 2 years also take Enbrel, and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people have Liver function test abnormal when taking Erelzi. It is created by eHealthMe based on reports of 11,624 people who have side effects when taking Erelzi from the FDA, and is updated regularly.
What is Erelzi?
Erelzi has active ingredients of etanercept-szzs. eHealthMe is studying from 11,625 Erelzi users. Check the latest studies of Erelzi.
What is Liver function test abnormal?
Liver function test abnormal is found to be associated with 1,494 drugs and 1,963 conditions by eHealthMe. Check the latest studies of Liver function test abnormal.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
11,624 people reported to have side effects when taking Erelzi.
Among them, 72 people (0.62%) have Liver function test abnormal.

Among these 72 people:
How long have people been on Erelzi when they have Liver function test abnormal? *
- < 1 month: 20 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 80 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Liver function test abnormal when taking Erelzi? *
- female: 64.79 %
- male: 35.21 %
What is the age of people who have Liver function test abnormal when taking Erelzi? *
- 0-1: 1.54 %
- 2-9: 27.69 %
- 10-19: 27.69 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 13.85 %
- 50-59: 9.23 %
- 60+: 20.0 %
What are other drugs people take besides Erelzi? *
- Enbrel: 47 people, 65.28%
- Humira: 45 people, 62.50%
- Actemra: 39 people, 54.17%
- Orencia: 39 people, 54.17%
- Triamcinolone: 37 people, 51.39%
- Methotrexate: 26 people, 36.11%
- Xeljanz Xr: 23 people, 31.94%
- Sulfasalazine: 23 people, 31.94%
- Prednisone: 22 people, 30.56%
- Hydroxychloroquine Sulfate: 21 people, 29.17%
What are other side effects people have besides Liver function test abnormal? *
- Drug Ineffective: 67 people, 93.06%
- C-Reactive Protein Increased: 51 people, 70.83%
- Pleural Effusion (water on the lungs): 48 people, 66.67%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 47 people, 65.28%
- Hypokalemia (low potassium): 45 people, 62.50%
- Mobility Decreased (ability to move is reduced): 41 people, 56.94%
- Diarrhea: 40 people, 55.56%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 40 people, 55.56%
- Weight Loss: 39 people, 54.17%
- Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 39 people, 54.17%
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 52 people, 72.22%
- Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 39 people, 54.17%
- Seasonal Allergy (allergic condition due to certain season): 30 people, 41.67%
- Rhinitis Perennial (an inflammatory condition of the nose characterized by nasal obstruction, sneezing, itching): 19 people, 26.39%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 15 people, 20.83%
- Allergic Rhinitis: 10 people, 13.89%
- Psoriasis (immune-mediated disease that affects the skin): 9 people, 12.50%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 12.50%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 9.72%
* Approximation only. Some reports may have incomplete information.
Do you take Erelzi and have Liver function test abnormal?
- Check whether Liver function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Erelzi:
- Erelzi (11,625 reports)
Liver function test abnormal treatments and more:
- Liver function test abnormal (39,450 reports)
How severe was Liver function test abnormal and when was it recovered:
Expand to all the drugs that have ingredients of etanercept-szzs:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Erelzi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Liver function test abnormal:
- Liver function test abnormal (1,495 drugs)
Browse all the conditions that are associated with Liver function test abnormal:
- Liver function test abnormal (1,963 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on etanercept-szzs (the active ingredients of Erelzi) and Erelzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lipitor cause Poor Venous Access? - 3 seconds ago
- Could Rogaine cause Abdominal Pain? - 5 seconds ago
- Could Naproxen cause Haemoglobin Decreased? - 23 seconds ago
- Could Robaxin cause Diaphragmatic Hernia? - 23 seconds ago
- Could Rituxan cause Hot Flush? - 24 seconds ago
- Could Rivaroxaban cause Abdominal Pain? - 26 seconds ago
- Could Rituxan cause Oedema Lower Limb? - 26 seconds ago
- Could Ritalin cause Mobility Decreased? - 28 seconds ago
- Could Crixivan cause Breast Infection? - 30 seconds ago
- Could Risperidone cause Myoclonic Epilepsy? - 32 seconds ago